News
CVSI
0.030
0.00%
0.000
CV Sciences announces annual shareholder meeting
PUBT · 1d ago
Weekly Report: what happened at CVSI last week (0406-0410)?
Weekly Report · 3d ago
CV Sciences cuts note conversion price to $0.03 in debt amendment
Reuters · 5d ago
Weekly Report: what happened at CVSI last week (0330-0403)?
Weekly Report · 04/06 10:23
Weekly Report: what happened at CVSI last week (0323-0327)?
Weekly Report · 03/30 10:23
CV Sciences outlines non-cannabinoid product launches and margin gains as company targets cash flow breakeven through 2026
Seeking Alpha · 03/26 22:16
CV Sciences FY2025 net loss narrows to $(958,000); product sales drop 12.2% to $13.8 million
Reuters · 03/26 21:15
CV Sciences Reports 2025 Results and Profitability Improvements
TipRanks · 03/26 20:42
CV Sciences Q4 sales fall
Reuters · 03/26 20:10
CV Sciences FY2025 operating loss narrows to $0.5 million; revenue drops 12.2% to $13.8 million on lower sales volume
Reuters · 03/26 20:08
CV Sciences Q4 Sales $3.307M Down From $3.884M YoY.
Benzinga · 03/26 20:04
CV Sciences Non-GAAP EPS of $0.00, revenue of $13.79M
Seeking Alpha · 03/26 20:04
CV SCIENCES Q4 SALES USD 3.307 MILLION
Reuters · 03/26 20:00
CV Sciences to release full-year and Q4 2025 results and host investor conference call
Reuters · 03/24 21:00
Weekly Report: what happened at CVSI last week (0316-0320)?
Weekly Report · 03/23 10:20
Congressman introduces bill for cannabis businesses to list on stock exchanges
TipRanks · 03/19 15:20
Study says cannabis shows little benefit for mental disorders, Reuters says
TipRanks · 03/17 10:40
Weekly Report: what happened at CVSI last week (0309-0313)?
Weekly Report · 03/16 10:19
CV Sciences Restructures Debt with New Convertible Note Deal
TipRanks · 03/11 04:22
CV Sciences adds $0.06-per-share conversion feature to outstanding notes in debt restructuring
Reuters · 03/10 21:00
More
Webull provides a variety of real-time CVSI stock news. You can receive the latest news about Cv Sciences through multiple platforms. This information may help you make smarter investment decisions.
About CVSI
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.